PPL-X1

Serial Number 98454234
730

Registration Progress

Application Filed
Mar 18, 2024
Under Examination
Dec 17, 2024
Approved for Publication
Nov 5, 2024
Published for Opposition
Nov 5, 2024
Registered

Attorney Assistance

Statement of Use Due - Extension 1 Granted
Due: Dec 17, 2025 135 days

Trademark Image

PPL-X1

Basic Information

Serial Number
98454234
Filing Date
March 18, 2024
Published for Opposition
November 5, 2024
Drawing Code
4

Status Summary

Current Status
Active
Status Code
730
Status Date
Jun 16, 2025
Application
Pending
Classes
005

Rights Holder

Phoenix Peptides LLC

16
Address
4 Mateo Drive
Tiburon, CA 94920

Ownership History

Phoenix Peptides LLC

Original Applicant
16
Tiburon, CA

Phoenix Peptides LLC

Owner at Publication
16
Tiburon, CA

Legal Representation

Attorney
Matthew A. Newboles

USPTO Deadlines

Next Deadline
135 days remaining
Statement of Use Due - Extension 1 Granted
Due Date
December 17, 2025
Extension Available
Until December 17, 2025

Application History

12 events
Date Code Type Description Documents
Jun 17, 2025 EXRA E NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED Loading...
Jun 16, 2025 EX1G S SOU EXTENSION 1 GRANTED Loading...
Jun 16, 2025 EXT1 S SOU EXTENSION 1 FILED Loading...
Jun 16, 2025 EEXT I SOU TEAS EXTENSION RECEIVED Loading...
Dec 17, 2024 NOAM E NOA E-MAILED - SOU REQUIRED FROM APPLICANT Loading...
Nov 5, 2024 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Nov 5, 2024 PUBO A PUBLISHED FOR OPPOSITION Loading...
Oct 16, 2024 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Sep 26, 2024 CNSA P APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Sep 26, 2024 DOCK D ASSIGNED TO EXAMINER Loading...
Aug 12, 2024 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Mar 18, 2024 NWAP I NEW APPLICATION ENTERED Loading...

Detailed Classifications

Class 005
medicines, drugs and active synthetic peptides used for the prevention and treatment of inflammatory diseases, autoimmune diseases, immune-mediated diseases, infectious diseases, diseases of the central nervous system ("CNS") and abatement of acute and chronic rejection of tissue and organ in transplant recipients

Classification

International Classes
005